Drug Trial Radar · NCT07570758
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
Last checked: Nov 19, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
May 28, 2026
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- ERX PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to assess the safety and tolerability of oral dose ERX1000 in obese subjects.
Conditions
- Obesity & Overweight
Interventions
ERX1000Drug
2mg tablet administered orally twice weekly.
PlaceboOther
2mg Placebo tablet identical in appearance to 2mg ERX1000 tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Body Weight of Participants from Baseline to Weeks 12 and 24Time frame: From enrollment to the end of treatment at Week 24.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Monroe Biomedical Research
Louisville, Kentucky · Recruiting
Monroe Biomedical Research
Monroe, North Carolina · Recruiting
Monroe Biomedical Research
North Charleston, South Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.